Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Proc Natl Acad Sci U S A ; 110(37): E3526-34, 2013 Sep 10.
Artículo en Inglés | MEDLINE | ID: mdl-23980168

RESUMEN

An arthropod-specific peptidergic system, the neuropeptide designated here as natalisin and its receptor, was identified and investigated in three holometabolous insect species: Drosophila melanogaster, Tribolium castaneum, and Bombyx mori. In all three species, natalisin expression was observed in 3-4 pairs of the brain neurons: the anterior dorso-lateral interneurons, inferior contralateral interneurons, and small pars intercerebralis neurons. In B. mori, natalisin also was expressed in two additional pairs of contralateral interneurons in the subesophageal ganglion. Natalisin-RNAi and the activation or silencing of the neural activities in the natalisin-specific cells in D. melanogaster induced significant defects in the mating behaviors of both males and females. Knockdown of natalisin expression in T. castaneum resulted in significant reduction in the fecundity. The similarity of the natalisin C-terminal motifs to those of vertebrate tachykinins and of tachykinin-related peptides in arthropods led us to identify the natalisin receptor. A G protein-coupled receptor, previously known as tachykinin receptor 86C (also known as the neurokinin K receptor of D. melanogaster), now has been recognized as a bona fide natalisin receptor. Taken together, the taxonomic distribution pattern of the natalisin gene and the phylogeny of the receptor suggest that natalisin is an ancestral sibling of tachykinin that evolved only in the arthropod lineage.


Asunto(s)
Proteínas de Drosophila/fisiología , Fertilidad/fisiología , Proteínas de Insectos/fisiología , Insectos/fisiología , Neuropéptidos/fisiología , Conducta Sexual Animal/fisiología , Taquicininas/fisiología , Secuencia de Aminoácidos , Animales , Bombyx/genética , Bombyx/fisiología , Encéfalo/citología , Encéfalo/metabolismo , Secuencia Conservada , Proteínas de Drosophila/antagonistas & inhibidores , Proteínas de Drosophila/genética , Drosophila melanogaster/genética , Drosophila melanogaster/fisiología , Femenino , Fertilidad/genética , Proteínas de Insectos/antagonistas & inhibidores , Proteínas de Insectos/genética , Insectos/genética , Interneuronas/metabolismo , Masculino , Datos de Secuencia Molecular , Neuropéptidos/antagonistas & inhibidores , Neuropéptidos/genética , Filogenia , Interferencia de ARN , Receptores de Taquicininas/genética , Receptores de Taquicininas/fisiología , Transducción de Señal , Taquicininas/antagonistas & inhibidores , Taquicininas/genética , Tribolium/genética , Tribolium/fisiología
2.
Res Sq ; 2023 Jun 08.
Artículo en Inglés | MEDLINE | ID: mdl-37333401

RESUMEN

The neutrophil to lymphocyte ratio (NTLR) and absolute lymphocyte count (ALC) recovery are prognostic across many cancers. We investigated whether NLTR predicts SBRT success or survival in a metastatic sarcoma cohort treated with SBRT from 2014 and 2020 (N = 42). Wilcox Signed Rank Test and Friedman Test compare NTLR changes with local failure vs. local control (N = 138 lesions). Cox analyses identified factors associated with overall survival. If local control was successful, NLTR change was not significant (p = 0.30). However, NLTR significantly changed in patients local failure (p = 0.027). The multivariable Cox model demonstrated higher NLTR before SBRT was associated with worse overall survival (p = 0.002). The optimal NTLR cut point was 5 (Youden index: 0.418). One-year overall survival in SBRT metastatic sarcoma cohort was 47.6% (CI 34.3%-66.1%). Patients with an NTLR above 5 had a one-year overall survival of 37.7% (21.4%-66.3%); patients with an NTLR below 5 had a significantly improved overall survival of 63% (43.3%-91.6%, p = 0.014). Since NTLR at the time of SBRT was significantly associated with local control success and overall survival in metastatic sarcoma treated with SBRT, future efforts to reduce tumor inhibitory microenvironment factors and improved lymphocyte recovery should be investigated.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA